Resveratrol - Nahrungsergänzungsmittel zur Unterstützung der Regeneration

Resveratrol is a naturally occurring polyphenolic compound most concentrated in grape skins (reaching up to 100 milligrams per gram of dry weight), as well as in the leaves, shoots, roots, and seeds of the grapevine. Additionally, this bioactive molecule is present in other fruits—including raspberries, cranberries, strawberries, blueberries, and apples—as well as in peanuts and select herbs. Classified as a stilbenoid, a class of organic compounds derived from stilbene, resveratrol exhibits a multifaceted biological profile characterized by potent antioxidant, anti-inflammatory, cardioprotective, anticancer, glucose-modulating, and neuroprotective properties. Furthermore, due to its capacity to influence energy metabolism, resveratrol is frequently advocated as a dietary supplement to enhance physical endurance, facilitate muscle recovery, and promote fat mass reduction in physically active individuals, including competitive athletes.

Emerging scientific evidence derived from animal-based experimental models suggests that resveratrol—a naturally occurring polyphenolic compound found in red wine, berries, and certain plants—may substantially enhance physical performance by promoting mitochondrial biogenesis and augmenting mitochondrial density within skeletal muscle fibers. Often referred to as the "cellular powerhouses," mitochondria are integral to aerobic respiration, where they facilitate the oxidative breakdown of lipids, carbohydrates, and proteins into high-energy adenosine triphosphate (ATP) molecules, which are essential for sustaining prolonged physical exertion. An increased mitochondrial volume within muscle tissue enables more efficient ATP synthesis during exercise, thereby delaying the onset of fatigue and improving overall endurance capacity. Additionally, resveratrol exhibits robust antioxidant properties, effectively scavenging excessive reactive oxygen species (ROS) generated during high-intensity workouts—compounds that, when unchecked, can induce oxidative damage to cellular structures. The compound also functions as a selective inhibitor of cyclooxygenase-2 (COX-2), an enzyme implicated in inflammatory pathways, thereby potentially mitigating exercise-induced microtrauma and accelerating post-exercise recovery. While these biochemical mechanisms position resveratrol as a promising ergogenic aid for both elite athletes and recreational exercisers, the current body of research remains predominantly limited to *in vitro* cell culture studies and a handful of *in vivo* clinical trials. One notable investigation involving isolated muscle cells from healthy athletes demonstrated that exposure to a 100-micromolar concentration of resveratrol significantly attenuated oxidative DNA damage—a finding that implies a protective role against training-related cellular stress. Nevertheless, comprehensive, large-scale human studies are still required to definitively establish the therapeutic and performance-enhancing efficacy of this polyphenol in real-world athletic applications.

While scientific evidence supporting resveratrol’s capacity to significantly extend lifespan remains limited and necessitates further clinical investigation, its multifaceted biological activities suggest a substantial potential to enhance overall health outcomes. Most notably, the compound demonstrates promising effects in modulating glucose metabolism—regular supplementation has been shown in controlled trials involving type 2 diabetes patients to improve tissue insulin sensitivity and reduce fasting blood glucose levels. Furthermore, resveratrol exhibits a broad spectrum of cardioprotective actions, including the inhibition of platelet aggregation, attenuation of inflammatory markers within the vascular endothelium, reduction of arterial blood pressure, and suppression of low-density lipoprotein (LDL) oxidation—all of which collectively mitigate the risk of atherosclerosis and its sequelae. Emerging preclinical research, particularly in obese rodent models, additionally indicates that this polyphenol may regulate organismal energy homeostasis by promoting mitochondrial biogenesis and modulating the expression of lipid metabolism-related genes, thereby potentially facilitating adipose tissue reduction and counteracting obesity development.

Resveratrol, a polyphenolic compound recognized for its antioxidant properties, exhibits notably low bioavailability—approximately 10%—which necessitates its administration in concentrated supplemental forms to elicit a physiologically meaningful response. Attempting to obtain therapeutic levels of this compound through wine consumption poses unacceptable health risks due to ethanol content, rendering this approach impractical for clinical purposes. The compound is commercially available in capsule and tablet formulations containing standardized red wine extracts, though it is also frequently incorporated into broad-spectrum antioxidant blends or phytonutrient-rich supplements. However, product quality varies significantly, with resveratrol concentrations ranging from 50% to as high as 99% purity. Preclinical research, predominantly conducted in animal models, has typically employed dosages of 22 mg per kilogram of body weight, yet robust human data remain scarce. Given the limited clinical evidence, cautious adherence to existing literature-based guidelines—while accounting for individual metabolic variations—is strongly advised.